Track the Nexalis Therapeutics Ltd share price and the full management transaction log of the company, a listed equity based in Australia. Shares are listed on the AU market, under the oversight of ASX. Operating in the Health Care sector, Nexalis Therapeutics Ltd has recorded 4 reports. Market capitalisation: €2.8m. The latest transaction was disclosed on 30 July 2026 (Change in Substantial Holding). Among the most active insiders: NFPFRN (if applicable). Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
4 of 4 declarations
Nexalis Therapeutics Ltd is a company focused on developing innovative treatments in the healthcare and pharmaceutical sector. It is listed on the XASX market.